All In Biotech

Drug Trial Radar · NCT07663630

A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Body Weight Loss

AN INTERVENTIONAL, PHASE 1B, DOUBLE-BLIND, RANDOMIZED, SPONSOR-OPEN, 2-ARM STUDY TO INVESTIGATE THE EFFECT OF PONSEGROMAB ON SKELETAL MUSCLE MASS AND PHYSICAL FUNCTION IN ADULT PARTICIPANTS WITH NON-SMALL CELL LUNG CANCER ASSOCIATED CACHEXIA

Last checked: Nov 19, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

80

Planned (sponsor's estimate)

Start

Oct 23, 2026

Primary completion

May 6, 2028

Study completion Jul 1, 2029

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Jun 23, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Supportive care
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Study to investigate the effect of ponsegromab on skeletal muscle mass and physical function in adult participants with non-small cell lung cancer associated cachexia.

Conditions

  • Non-small Cell Lung Cancer (NSCLC)
  • Cachexia

Interventions

  • ponsegromabDrug

    Double-Blind ponsegromab Treatment

  • placeboDrug

    Double-Blind placebo Treatment

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent change from baseline in Lumbar Skeletal Muscle IndexTime frame: Baseline, Week 12

Locations

7 sites in 2 countries. Site status is shown where the registry gives one.

  • Cancer Care Specialists of Illinois-Decatur

    Decatur, Illinois

  • Decatur Memorial Hospital

    Decatur, Illinois

  • Cancer Care Specialists of Illinois - Cancer Care Center of O'Fallon

    O'Fallon, Illinois

  • Dallas Cancer Specialists

    Garland, Texas

  • Houston Cancer Treatment Centers

    Houston, Texas

  • Lumi Research

    Houston, Texas

  • The Universityof Hong Kong-Shenzhen Hospital

    Shenzhen, Guangdong, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.